Perfil
Thomas Fairfull was the founder of Quantum BioPharma Ltd., founded in 1994, serving as President, Chief Executive Officer & Director from 1994 to 2018.
Mr. Fairfull was the founder of dynaCERT, Inc., founded in 2004, serving as Chairman & Chief Financial Officer in 2009.
Mr. Fairfull was the founder of FV Pharma, Inc., founded in 2011, serving as President & Chief Executive Officer from 2011 to 2019.
Mr. Fairfull is currently President, Chief Executive Officer & Director at Kleen HY-DRO-GEN, Inc. since 2019.
Former positions include Director at Cannara Biotech, Inc.
Cargos activos de Thomas Fairfull
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Thomas Fairfull.
| Empresas | Cargo | Fin |
|---|---|---|
| CANNARA BIOTECH INC. | Director/Miembro de la Junta | 24/05/2019 |
FV Pharma, Inc.
FV Pharma, Inc. BiotechnologyHealth Technology Produces medical cannabis products | Director Ejecutivo | 13/03/2019 |
| QUANTUM BIOPHARMA LTD. | Fundador | 29/10/2018 |
| DYNACERT INC. | Fundador | 13/08/2009 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
dynaCERT, Inc.
dynaCERT, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures, distributes and markets transportable hydrogen and oxygen generator products | Producer Manufacturing |
FV Pharma, Inc.
FV Pharma, Inc. BiotechnologyHealth Technology Produces medical cannabis products | Health Technology |
FSD Pharma, Inc.
FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
Cannara Biotech, Inc.
Cannara Biotech, Inc. Agricultural Commodities/MillingProcess Industries Engages in indoor cultivation, processing and selling of dried cannabis products | Process Industries |
- Bolsa de valores
- Insiders
- Thomas Fairfull
















